Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARCH Venture Partners
Biotech
Arch-backed tRNA biotech shutters after viewing preclinical data
HC Bioscience is shutting down after conducting preclinical models for a tRNA asset designed to treat hemophilia A.
Gabrielle Masson
Mar 18, 2025 10:15am
Arbor sails into rocky gene editing waters with $74M
Mar 18, 2025 6:30am
Tenvie takes off with $200M, assets and exec from Denali
Jan 8, 2025 8:00am
City Tx breaks ground with $135M, blueprints from Maraganore
Oct 8, 2024 10:38am
Arch closes $3B-plus fund to foster biopharma upstarts
Sep 26, 2024 10:24am
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
Sep 24, 2024 7:00am
